Clinical Trial Update: Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of intravenous and intraperitoneal paclitaxel, intraperitoneal cisplatin, and intravenous bevacizumab as initial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer, Primary PERITONEUM | Phase 2 | Status: COMPLETED | Results posted: 2016-01-20